Immunotherapy | Tumor

CURE’s immunotherapy page features the latest cancer news and updates on immunotherapy Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in immunotherapy.

Opdivo Improves Time to Disease Recurrence in Stage 2B and 2C Skin Cancer

October 20th 2022, 7:00pm

Article

When given after surgery, Opdivo improved relapse-free survival compared to placebo in patients with stage 2B or 2C skin cancer, according to recent results from the CheckMate-76K clinical trial.

Investigational Tumor-Infiltrating Lymphocyte Therapy in Solid Tumors

September 19th 2022, 7:22pm

Article

Injectable Tecentriq Is Efficacious, Reduces Treatment Time for Lung Cancer

August 2nd 2022, 3:00pm

Article

Subcutaneous (injectable) Tecentriq had similar movement throughout the body, while saving on treatment time compared to intravenous administration of the drug in a group of patients with non-small cell lung cancer.

In Recent Decades, Immunotherapy Extended Advanced Melanoma Survival from Months to Years

July 11th 2022, 3:00pm

Video

Thanks to the FDA approval of immunotherapy agents, the average survival for patients for stage 4 melanoma has drastically increased over the past 20 years, an expert explained.

FDA Approves Kymriah for Relapsed/Refractory Follicular Lymphoma

May 31st 2022, 1:59pm

Article

Kymriah, a CAR-T cell therapy, was approved by the Food and Drug Administration for the treatment of patients with pretreated, relapsed/refractory follicular lymphoma.

Skin Cancer Diagnosis, Older Age May Be Associated With Increased Risk for Rare Skin Condition from Immunotherapy Treatment

April 19th 2022, 3:00pm

Article

Patients within the study who developed the rare skin condition were more likely to experience better tumor responses than those who did not develop the side effect.

Invading Cancer Cells With Immunotherapy Combinations

March 16th 2022, 3:00pm

Article

Recent research has demonstrated the ability of immunotherapy combinations to target advanced melanoma.

Immunotherapy Side Effects: ‘No Organ System Potentially Unaffected’

November 23rd 2021, 4:00pm

Article

Immunotherapy side effects are a different than those of chemotherapy and other cancer treatments. Patients should know when to seek emergency care and what to communicate to clinicians.

The 'Promise' of Precision Medicine: Making Incurable Cancers Into Chronic Diseases

October 1st 2021, 7:00pm

Article

One oncologist highlighted the knowledge base of the immunotherapy and targeted therapy and how they interact with cancer cells.

Further Evaluating Biomarkers May Help to Better Interpret Which Patients Are Eligible For Immunotherapy

September 29th 2021, 7:00pm

Article

Getting rid of the "blanket statement" and looking deeper into genetics may allow patients with cancer who are older than 60 years to become eligible for immunotherapy, highlighting the importance of further research on the topic.